Escitalopram Treatment In Acute Stroke "ESTIAS"


Phase 4 Results N/A

Summary of Purpose

Growing international scientific evidence has indicated a positive effect of SSRI treatment (serotonin reuptake inhibitors) after stroke, beyond its antidepressant effect. We wish to conduct a prospective randomised double blind placebo-controlled multicenter study of the combined neuroprotective and antithrombotic... Trial Stopped: Study medication could not be supplied. An alternative project will be conducted

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 June 2012.

Unavailable 20 Mar 2012 Unavailable Unavailable 1 Jun 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment